CURE semiconductor platform
Search documents
First Solar, Inc. Q4 2025 Earnings Call Summary
Yahoo Finance· 2026-02-25 13:30
Core Insights - The company achieved record module sales of 17.5 GW in 2025, marking a 24% year-over-year increase despite challenges in shipment profiles and regulatory environments [1] - Management emphasized contract certainty in pricing and delivery to maintain customer trust amid changing tariff scenarios and regulatory developments [1] - A disciplined approach to customer contracting led to 2.3 GW of new gross bookings, including 1 GW in the U.S. utility-scale market at an average selling price (ASP) of $0.364 per watt [1] - Operational growth was bolstered by the start of commercial production at the Louisiana factory and plans for new finishing capacity in South Carolina to enhance domestic production [1] - The company is utilizing its thin-film expertise to advance the CURE semiconductor platform and next-generation perovskite programs, targeting superior lifetime energy yield compared to crystalline silicon [1] - Management actively enforced intellectual property rights, including TOPCon patents, to safeguard its technological advantages against foreign manufacturers [1] - Strategic debookings of 8.3 GW occurred mainly due to contract terminations following customer breaches, allowing the company to maintain a high-quality, forward-earning backlog [1]